je.st
news
A Real and Urgent Need for Novel Cancer Diagnostics Tests
2013-02-05 12:36:36| drugdiscoveryonline Home Page
New analysis from Frost & Sullivan (http://www.healthcare.frost.com), Western European In Vitro Cancer Diagnostics Market, finds that the market earned revenues of $736.0 million in 2011 and estimates this to reach $1519.8 million in 2019. The research covers immunoassay, immunohistochemistry, nucleic acid testing (NAT), clinical chemistry and other diagnostic methods.
Tags: real
tests
cancer
novel
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||